Showing results (1661-1670 of 1,899) with videos related to
Sort By:
Pageof 190
Immunotherapy|November 5, 2020
Immune checkpoint inhibitor use, multimorbidity and healthcare expenditures among older adults with late-stage melanomaPragya Rai, Chan Shen, Joanna Kolodney, et al.Immunotherapy|September 9, 2020
Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case reportXerxes Pundole, Amy Little Jones, Michael T Tetzlaff, et al.Immunotherapy|September 4, 2020
Cost-effectiveness of pembrolizumab plus axitinib as first-line therapy for advanced renal cell carcinomaJiaxin Zhu, Tiantian Zhang, Ning Wan, et al.Immunotherapy|September 7, 2020
Dupilumab use in atopic dermatitis and beyond in skin diseasesKayla Fourzali, Rachel Shireen Golpanian, Gil YosipovitchImmunotherapy|February 19, 2020
Use of recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin in elderly patientsPieter van Paassen, David Pittrow, Clemens Scheidegger, et al.Immunotherapy|January 9, 2020
Real-life effect of a microcrystalline tyrosine adjuvanted mite immunotherapy in patients with allergic rhinitisAlbert Roger, Alfons Malet, Victoria Moreno, et al.Immunotherapy|January 10, 2020
M2 macrophage immunotherapy abolishes glucose intolerance by increasing IL-10 expression and AKT activationDiana Vega-Galaviz, Georgina Del Vecchyo-Tenorio, Raúl Alcántara-Suárez, et al.Immunotherapy|January 10, 2020
CD3D is associated with immune checkpoints and predicts favorable clinical outcome in colon cancerYi Yang, Yiwen Zang, Chuang Zheng, et al.Immunotherapy|February 21, 2020
Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposisJohn V Boyle, Kent Lam, Joseph K HanImmunotherapy|February 25, 2020
Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa studyMelissa Bersanelli, Sebastiano Buti, Giuseppe Luigi Banna, et al.Pageof 190